Olmetec

Olmetec

olmesartan

Manufacturer:

Pfizer
Concise Prescribing Info
Contents
Olmesartan medoxomil
Dosage/Direction for Use
Adult Start w/ 10 mg once daily & may be increased in patients whose BP is not adequately controlled at this dose to 20 mg once daily as the optimal dose. If additional BP reduction is required, dose may be increased up to a max of 40 mg daily or w/ hydrochlorothiazide therapy. Elderly & mild to moderate renal impairment (CrCl 20-60 mL/min) Max: 20 mg once daily.
Administration
May be taken with or without food.
Contraindications
Hypersensitivity. Biliary obstruction. Do not co-administer aliskiren w/ olmesartan medoxomil in patients w/ diabetes. 2nd & 3rd trimesters of pregnancy & lactation.
Special Precautions
Intravascular vol depletion; conditions w/ stimulation of the renin-angiotensin-aldosterone system; renovascular HTN; electrolyte imbalance; sprue-like enteropathy; renal impairment & kidney transplantation; hepatic impairment; hyperkalemia; lithium; aortic or mitral valve stenosis; obstructive hypertrophic cardiomyopathy & primary aldosteronism; ethnic differences. May impair ability to drive or operate machinery. Childn & adolescent ≤18 yr.
Adverse Reactions
Dizziness, vertigo, hypotension, angina pectoris, bronchitis, cough, pharyngitis, rhinitis, abdominal pain, diarrhea, dyspepsia, gastroenteritis, nausea, rash, arthritis, back & skeletal pains, hematuria, UTI, chest pain, fatigue, influenza-like symptoms, peripheral oedema, pain, increased creatinine phosphokinase, hypertriglyceridaemia, hyperuricaemia, hyperkalaemia, liver enzymes elevations.
Drug Interactions
Aliskiren. Colesevelam HCl. K supplements & K-sparing diuretics, salt substitutes containing K may lead to increase in serum K. NSAIDs & AIIA may decrease glomerular filtration. Al- or Mg hydroxide-containing antacids reduce bioavailability of olmesartan. Increased serum lithium conc & toxicity during concomitant administration.
ATC Classification
C09CA08 - olmesartan medoxomil ; Belongs to the class of angiotensin II receptor blockers (ARBs). Used in the treatment of cardiovascular disease.
Presentation/Packing
Form
Olmetec tab 20 mg
Packing/Price
30's (Rp427,905/pak)
Form
Olmetec tab 40 mg
Packing/Price
30's (Rp523,646/pak)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in